Company profile: Vitestro
1.1 - Company Overview
Company description
- Provider of autonomous blood drawing technology: an AI-based, ultrasound-guided robotic device that automates blood collection from tourniquet application to bandage placement; Vitestro Academy training for healthcare professionals on safe use and workflows; and the A.D.O.P.T. trial evaluating performance and safety in 10,000+ patients toward CE marking by end of 2024.
Products and services
- Autonomous Blood Drawing Device: Builds an AI-based, ultrasound-guided imaging and robotic needle insertion assembly enabling accurate, secure blood collection, fully automated from tourniquet application to bandage placement
- A.D.O.P.T. Trial: Conducts an over-10,000-patient scale clinical evaluation to assess performance and safety of the device, targeting CE marking by the end of 2024
- Vitestro Academy: Delivers a process-focused training program for healthcare professionals on safe use and novel work processes of the autonomous blood drawing technology
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Vitestro
Drew Scientific
HQ: United States
Website
- Description: Provider of analytical instruments and reagents worldwide, including cell counters for clinical hematology, cell counters for veterinary hematology and research, hemoglobin analyzers for diabetes (HbA1c), and related reagents and controls.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Drew Scientific company profile →
Entegrion
HQ: United States
Website
- Description: Provider of innovative life sciences solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Entegrion company profile →
Endovascular Engineering
HQ: United States
Website
- Description: Provider of preclinical mechanical thrombectomy solutions, including the Hēlo™ G1 Thrombectomy System for non-surgical removal of thrombi and emboli from venous vasculature. Features include a self-expanding funnel with wide distal opening for large bore clot engagement, dual-action high-speed agitation with physician-controlled aspiration, and a single-pass catheter with integrated handle for navigating complex anatomies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Endovascular Engineering company profile →
Haemonetics
HQ: United States
Website
- Description: Provider of blood and plasma supplies and services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Haemonetics company profile →
Quotient
HQ: United States
Website
- Description: Provider of transfusion and blood bank diagnostics solutions, including MosaiQ, a fully automated in‑vitro platform performing multiple tests on a single patient sample to optimize laboratory resources and shorten time to diagnosis; Alba, manual reagents for blood bank diagnostics with technical and customer support; and MosaiQ AiPlex CTD, a microarray immunoassay for connective tissue diseases that detects multiple autoantibodies in one panel.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Quotient company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Vitestro
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Vitestro
2.2 - Growth funds investing in similar companies to Vitestro
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Vitestro
4.2 - Public trading comparable groups for Vitestro
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →